NewsEpisurf Medical enters into distribution agreement in Hong Kong and establishes subsidiary in the US

Episurf Medical (NASDAQ: EPIS B) today announces that the company has entered into a distribution agreement in Hong Kong with Pacific Medical Systems. This is a first step in the company’s strategy of opening new markets in Asia. Pål Ryfors, CEO Episurf Medical, says that “we have received very encouraging feedback from leading surgeons in Hong Kong, confirming that Episealer® will help them to treat patients in the so-called treatment gap. We are happy to have appointed Pacific Medical Systems as our distributor, and Hong Kong will, as our first market in Asia where our technology is ready to be marketed, also be an important reference during our further expansion in the region.”

The company also communicates that it has established a subsidiary in the US, Episurf Medical Inc. This subsidiary is established for the purpose of conducting clinical studies for regulatory purposes in the US, as previously communicated.

For more  information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69